Lakewood-Amedex Biotherapeutics Inc (LABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,650 | 1,190 | 380 | 170 | -360 |
| Depreciation Amortization | 2,420 | 1,590 | 780 | 4,890 | 4,120 |
| Other Working Capital | -6,980 | -1,670 | 1,980 | -3,690 | -2,310 |
| Other Operating Activity | 20 | 10 | 30 | 2,000 | 1,690 |
| Operating Cash Flow | $-890 | $1,120 | $3,170 | $3,370 | $3,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,340 | -1,150 | -650 | -1,320 | -990 |
| Net Acquisitions | 0 | 0 | 0 | -13,140 | 0 |
| Other Investing Activity | -70 | -40 | 0 | 70 | -13,960 |
| Investing Cash Flow | $-1,410 | $-1,190 | $-650 | $-14,390 | $-14,950 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,380 | 570 | -2,420 | 11,640 | 11,880 |
| Financing Cash Flow | $2,380 | $570 | $-2,420 | $11,640 | $11,880 |
| Exchange Rate Effect | 8 | 0 | 8 | -10 | -10 |
| Beginning Cash Position | 1,370 | 1,370 | 1,370 | 760 | 760 |
| End Cash Position | 1,450 | 1,890 | 1,470 | 1,370 | 830 |
| Net Cash Flow | $80 | $510 | $100 | $600 | $60 |
| Free Cash Flow | |||||
| Operating Cash Flow | -890 | 1,120 | 3,170 | 3,370 | 3,140 |
| Free Cash Flow | -890 | 1,120 | 3,170 | 3,370 | 3,140 |